no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Acute aseptic arthritis: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data
|
Woerner, Andreas |
|
2019 |
37 |
2 |
p. 384-391 |
article |
2 |
Acute wheeze in the pediatric population: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
|
Katz, Mark A. |
|
2019 |
37 |
2 |
p. 392-399 |
article |
3 |
Adverse pregnancy outcomes and infant mortality after quadrivalent HPV vaccination during pregnancy
|
Faber, Mette Tuxen |
|
2019 |
37 |
2 |
p. 265-271 |
article |
4 |
Announcing the publication of the WHO immunological basis for immunization series module on pertussis vaccines
|
|
|
2019 |
37 |
2 |
p. 217-218 |
article |
5 |
Arthritis and arthralgia as an adverse event following immunization: A systematic literature review
|
Panozzo, Catherine A. |
|
2019 |
37 |
2 |
p. 372-383 |
article |
6 |
Causal relationship between immunological responses and adverse reactions following vaccination
|
Nakayama, Tetsuo |
|
2019 |
37 |
2 |
p. 366-371 |
article |
7 |
Comparison of vaccination with rhesus CMV (RhCMV) soluble gB with a RhCMV replication-defective virus deleted for MHC class I immune evasion genes in a RhCMV challenge model
|
Valencia, Sarah |
|
2019 |
37 |
2 |
p. 333-342 |
article |
8 |
Cost-effectiveness of adult vaccinations: A systematic review
|
Leidner, Andrew J. |
|
2019 |
37 |
2 |
p. 226-234 |
article |
9 |
Development of a US trust measure to assess and monitor parental confidence in the vaccine system
|
Frew, Paula M. |
|
2019 |
37 |
2 |
p. 325-332 |
article |
10 |
Editorial Board/Aims and Scope
|
|
|
2019 |
37 |
2 |
p. IFC |
article |
11 |
Global Funders Consortium for Universal Influenza Vaccine Development
|
Bresee, Joseph S. |
|
2019 |
37 |
2 |
p. 211-213 |
article |
12 |
Hepatitis B vaccines: WHO position paper, July 2017 – Recommendations
|
World Health Organization, |
|
2019 |
37 |
2 |
p. 223-225 |
article |
13 |
Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6–59 months of age: A phase 3, randomized, noninferiority study
|
Statler, Victoria A. |
|
2019 |
37 |
2 |
p. 343-351 |
article |
14 |
Immunogenicity of synthetic peptide constructs based on PvMSP9E795-A808, a linear B-cell epitope of the P. vivax Merozoite Surface Protein-9
|
Rodrigues-da-Silva, Rodrigo Nunes |
|
2019 |
37 |
2 |
p. 306-313 |
article |
15 |
Interventions to help people understand community immunity: A systematic review
|
Hakim, Hina |
|
2019 |
37 |
2 |
p. 235-247 |
article |
16 |
Licensing the first reduced, 6 µg dose whole virion, aluminum adjuvanted seasonal influenza vaccine – A randomized-controlled multicenter trial
|
Vajo, Zoltan |
|
2019 |
37 |
2 |
p. 258-264 |
article |
17 |
Measles vaccines: WHO position paper, April 2017 – Recommendations
|
World Health Organization, |
|
2019 |
37 |
2 |
p. 219-222 |
article |
18 |
Mixed mucosal-parenteral immunizations with the broadly conserved pathogenic Escherichia coli antigen SslE induce a robust mucosal and systemic immunity without affecting the murine intestinal microbiota
|
Naili, Ilham |
|
2019 |
37 |
2 |
p. 314-324 |
article |
19 |
Motivation for participating in phase 1 vaccine trials: Comparison of an influenza and an Ebola randomized controlled trial
|
Cattapan, A. |
|
2019 |
37 |
2 |
p. 289-295 |
article |
20 |
Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies
|
Pan, William K. |
|
2019 |
37 |
2 |
p. 352-365 |
article |
21 |
Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine
|
Satzke, Catherine |
|
2019 |
37 |
2 |
p. 296-305 |
article |
22 |
TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice
|
Hegazy-Hassan, Wael |
|
2019 |
37 |
2 |
p. 248-257 |
article |
23 |
The uptake of adolescent vaccinations through the School Immunisation Program in specialist schools in Victoria, Australia
|
O'Neill, Jenny |
|
2019 |
37 |
2 |
p. 272-279 |
article |
24 |
Typhoid vaccines: WHO position paper, March 2018 – Recommendations
|
World Health Organization, |
|
2019 |
37 |
2 |
p. 214-216 |
article |
25 |
Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and the National Death Index.
|
Duszynski, Katherine M. |
|
2019 |
37 |
2 |
p. 280-288 |
article |